© 2004 by European Society of Cardiology
Copyright © 2004, European Society of Cardiology
Calcineurin–NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs
Division of Molecular Cardiovascular Biology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, USA
* Tel.: +1-513-636-3557; fax: +1-513-636-5958. Email address: jeff.molkentin{at}cchmc.org
Prolonged cardiac hypertrophy of pathologic etiology is associated with arrhythmia, sudden death, decompensation, and dilated cardiomyopathy. In an attempt to understand the mechanisms that underlie the hypertrophic response, extensive investigation has centered on a characterization of the molecular pathways that initiate or maintain the pathologic growth of individual cardiac myocytes. While a large number of signal transduction cascades have been identified as critical regulators of cardiac hypertrophy, here the scientific evidence implicating the protein phosphatase calcineurin (PP2B) and the mitogen-activated protein kinases (MAPK) as co-regulators of reactive hypertrophy will be discussed. Gain- and loss-of-function studies in genetically altered mice and in cultured cardiomyocytes have demonstrated the necessity and sufficiency of calcineurin to regulate pathologic cardiac hypertrophy. However, using similar approaches, the hypertrophic regulatory role attributed to various branches of the MAPK signaling pathway has been less conclusive, although a loose consensus suggests that the c-Jun N-terminal kinases (JNK) and p38 kinases function as mediators of dilated cardiomyopathy, while extracellular signal-regulated kinases (ERKs) function as regulators of hypertrophy. More recently, the actions of calcineurin and MAPK signaling pathways have been shown to be co-dependent such that unitary activation of calcineurin in myocytes leads to up-regulation in ERK and JNK signaling, but down-regulation in p38 signaling. Conversely, unitary activation of JNK or p38 in cardiac myocytes leads to down-regulation of calcineurin effectiveness by directly antagonizing nuclear factor of activated T cells (NFAT) nuclear occupancy. Thus, an emerging paradigm suggests that calcineurin–NFAT and MAPK signaling pathways are inter-dependent and together orchestrate the cardiac hypertrophic response.
KEYWORDS Calcineurin; Cardiac hypertrophy; MAPK; Heart failure; Signaling
Time for primary review 28 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. White, H. Ross, S. Levesque, L. Whittom, G. B Pelletier, N. Racine, S. Meloche, and L. Voisin Effects of Angiotensin-Converting Enzyme Inhibitor Versus Valsartan on Cellular Signaling Events in Heart Transplant Ann. Pharmacother., May 1, 2009; 43(5): 831 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Liu, M. Zi, J. Jin, S. Prehar, D. Oceandy, T. E. Kimura, M. Lei, L. Neyses, A. H. Weston, E. J. Cartwright, et al. Cardiac-Specific Deletion of Mkk4 Reveals Its Role in Pathological Hypertrophic Remodeling but Not in Physiological Cardiac Growth Circ. Res., April 10, 2009; 104(7): 905 - 914. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lombardi, G. Rodriguez, S. N. Chen, C. M. Ripplinger, W. Li, J. Chen, J. T. Willerson, S. Betocchi, S. A. Wickline, I. R. Efimov, et al. Resolution of Established Cardiac Hypertrophy and Fibrosis and Prevention of Systolic Dysfunction in a Transgenic Rabbit Model of Human Cardiomyopathy Through Thiol-Sensitive Mechanisms Circulation, March 17, 2009; 119(10): 1398 - 1407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Mackiewicz, M. Maczewski, A. Konior, J. O. Tellez, D. Nowis, H. Dobrzynski, M. R. Boyett, and B. Lewartowski Sarcolemmal Ca2+-ATPase ability to transport Ca2+ gradually diminishes after myocardial infarction in the rat Cardiovasc Res, February 15, 2009; 81(3): 546 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Meyer-Kirchrath, M. Martin, C. Schooss, C. Jacoby, U. Flogel, A. Marzoll, J. W. Fischer, J. Schrader, K. Schror, and T. Hohlfeld Overexpression of prostaglandin EP3 receptors activates calcineurin and promotes hypertrophy in the murine heart Cardiovasc Res, February 1, 2009; 81(2): 310 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Wang, Y. Song, D.-B. Chen, and J. Zheng Protein Phosphatase 3 Differentially Modulates Vascular Endothelial Growth Factor- and Fibroblast Growth Factor 2-Stimulated Cell Proliferation and Signaling in Ovine Fetoplacental Artery Endothelial Cells Biol Reprod, October 1, 2008; 79(4): 704 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shen, Z. Cseresnyes, Y. Liu, W. R. Randall, and M. F. Schneider Regulation of the nuclear export of the transcription factor NFATc1 by protein kinases after slow fibre type electrical stimulation of adult mouse skeletal muscle fibres J. Physiol., March 1, 2007; 579(2): 535 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yamada, G. C. Kane, A. Behfar, X.-K. Liu, R. B. Dyer, R. S. Faustino, T. Miki, S. Seino, and A. Terzic Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant J. Physiol., December 15, 2006; 577(3): 1053 - 1065. [Abstract] [Full Text] [PDF]
|
|